BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

May 08, 2017

|

NEW YORK (GenomeWeb) – Becton Dickinson today said it has commenced registered offerings of $2.25 billion of common stock and $2.25 billion of depositary shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

To read the full story....

Breaking News

Roche SARS-CoV-2 Antigen Test Nabs German Approval for At-Home Self-Testing

GenDx HLA Genotyping Products Receives Health Canada IVD Approval

In Brief This Week: Thermo Fisher, BioReference Laboratories, Hologic, Invitae, Danaher, and More

Natera Revenues Grow 35 Percent in Q4

NantHealth Q4 Revenues Flat From Year Ago

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

What's Popular?

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Kaya 17 Gets CE Mark for Point-of-Care Coronavirus Antigen Test

GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Sponsorships